HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Paolo Ascierto Selected Research

Paolo Ascierto Research Topics

Disease

9Melanoma (Melanoma, Malignant)
11/2021 - 06/2011
5Neoplasms (Cancer)
01/2019 - 02/2008
3Disease Progression
10/2020 - 04/2010
2Squamous Cell Carcinoma (Epidermoid Carcinoma)
07/2020 - 06/2011
1Brain Neoplasms (Brain Tumor)
11/2021
1Pneumonia (Pneumonitis)
11/2020
1Cytokine Release Syndrome
11/2020
1COVID-19
11/2020
1Residual Neoplasm
12/2018
1Neoplasm Metastasis (Metastasis)
12/2018
1Carcinogenesis
03/2013
1Exanthema (Rash)
06/2011
1Diarrhea
06/2011
1Keratoacanthoma
06/2011
1Fatigue
06/2011
1Arthralgia (Joint Pain)
06/2011
1Alopecia (Baldness)
06/2011
1Nausea
06/2011
1Non-Muscle Invasive Bladder Neoplasms
04/2010

Drug/Important Bio-Agent (IBA)

2Immune Checkpoint InhibitorsIBA
10/2020 - 01/2016
1L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2021
1dabrafenibIBA
11/2021
1trametinibIBA
11/2021
1tocilizumab (atlizumab)FDA Link
11/2020
1Interleukin-6 (Interleukin 6)IBA
11/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2020
1Biological ProductsIBA
01/2019
1Biomarkers (Surrogate Marker)IBA
12/2018
11-methyl-1-piperidinomethane sulfonateIBA
02/2016
1Microphthalmia-Associated Transcription FactorIBA
02/2016
1Cyclin-Dependent Kinases (cdk Proteins)IBA
02/2016
1VaccinesIBA
01/2016
1Monoclonal AntibodiesIBA
01/2016
1IpilimumabIBA
10/2013
1Proteins (Proteins, Gene)FDA Link
03/2013
1Interferon alpha-2 (Roferon-A)FDA Link
10/2012
1InterferonsIBA
10/2012
1Proto-Oncogene Proteins B-rafIBA
06/2011
1VemurafenibIBA
06/2011
1Dacarbazine (DIC)FDA LinkGeneric
06/2011
1GemcitabineFDA Link
04/2010
1AntibodiesIBA
02/2008

Therapy/Procedure

5Therapeutics
10/2020 - 10/2012
5Immunotherapy
07/2020 - 02/2008
1Retreatment
10/2020
1EAP protocol
10/2013
1Cystectomy
04/2010
1Biological Therapy
02/2008